New drug ABBV-547 enters first human safety trial

NCT ID NCT07232004

Recruiting now Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This early-stage study tests a single dose of ABBV-547 in healthy adults to check its safety, how the body processes it, and any side effects. About 121 participants in the US and Japan will receive either the drug or a placebo. The study has two parts with different dosing groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Acpru /Id# 278638
RECRUITING

Grayslake, Illinois, 60030, United States
Advanced Clinical Research Institute - Tampa /ID# 279342
RECRUITING

Tampa, Florida, 33607, United States
Austin Institute for Clinical Research - Pflugerville /ID# 279387
RECRUITING

Pflugerville, Texas, 78660, United States
Cenexel act- Anaheim Clinical Trials /ID# 279612
RECRUITING

Anaheim, California, 92801, United States
Center for Clinical Studies - Houston - Binz Street /ID# 279419
RECRUITING

Houston, Texas, 77004, United States
Dermatology Research Associates - Los Angeles /ID# 279383
RECRUITING

Los Angeles, California, 90045, United States
Dermatology Trial Associates /ID# 279984
RECRUITING

Bryant, Arkansas, 72022, United States
Equity Medical, LLC - Bronx /ID# 279808
RECRUITING

The Bronx, New York, 10455, United States
Fukuoka University Hospital /ID# 279530
RECRUITING

Fukuoka, 814-0180, Japan
Health Concepts /ID# 279529
RECRUITING

Rapid City, South Dakota, 57702, United States
Integrative Skin Science and Research - Location 2 /ID# 279386
RECRUITING

Sacramento, California, 95815, United States
MediSearch Clinical Trials /ID# 279416
RECRUITING

Saint Joseph, Missouri, 64506, United States
MetroBoston Clinical Partners /ID# 279992
RECRUITING

Boston, Massachusetts, 02135, United States
Minnesota Clinical Study Center /ID# 279987
RECRUITING

New Brighton, Minnesota, 55112, United States
Oregon Dermatology & Research Center /ID# 279391
RECRUITING

Portland, Oregon, 97210, United States
Skin Care Research Boca Raton /ID# 279988
NOT_YET_RECRUITING

Boca Raton, Florida, 33486-2269, United States
Skin Specialists /ID# 279531
RECRUITING

Omaha, Nebraska, 68144, United States
The Skin Center Dermatology Group /ID# 279983
RECRUITING

New City, New York, 10956-7153, United States
Total Dermatology /ID# 279798
RECRUITING

Birmingham, Alabama, 35203-4024, United States
Trueblue Clinical Research - Tampa /ID# 281757
NOT_YET_RECRUITING

Tampa, Florida, 33609, United States
University Dermatology & Vein Clinic - Darien /ID# 279986
NOT_YET_RECRUITING

Darien, Illinois, 60561, United States
University of the Ryukyus Hospital /ID# 279918
RECRUITING

Ginowan-shi, Okinawa, 901-2725, Japan
Wellness Clinical Research - Miami Lakes /ID# 279803
RECRUITING

Miami Lakes, Florida, 33016, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ABBV-547

What could go wrong

This is a very early Phase 1 trial in healthy volunteers, so it cannot show whether ABBV-547 works for any disease. The main goal is safety, not effectiveness.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEER